4 results

• Complications from Orbera and ReShape Intragastric Balloons for Weight Loss Result in Updated FDA Warnings

  April 28, 2020

  Russell Maas

  The FDA has added new warnings to Obera and ReShape weight loss balloons following reports of acute pancreatitis, surgical complications and deaths.

• Intragastric Balloon Deaths Lead To New FDA Warning Over Weight Loss Procedure

  June 5, 2018

  Russell Maas

  The FDA is requiring new label warnings of intragastric weight loss balloon surgeries, which have been linked to a number of deaths in recent years.

• Weight Loss Balloon Deaths Result in FDA Warning

  August 11, 2017

  Martha Garcia

  The FDA warns that at least five patient deaths have been linked to complications with intragastric weight loss balloons and investigators are still trying to ascertain the cause of those deaths.

• Weight Loss Balloons Linked To Pancreatitis, Over-Inflation Adverse Events: FDA Warns

  February 10, 2017

  Irvin Jackson

  The FDA warns that surgical balloons implanted in the stomach to promote weight loss can overinflate and could also cause cases of acute pancreatitis.